Publications by authors named "Hatami B"

Background: Cirrhosis is a medical condition marked by persistent liver damage, which leads to the development of fibrous tissue and compromised liver function. In the present study, we decided to investigate the possibility of a connection between the consumption of fermentable olig-, di-, monosaccharides, and polyols (FODMAPs) and mortality rates in cirrhotic patients by utilizing data obtained from a prospective cohort study.

Methods: This cohort study enrolled 166 ambulatory patients from two hospitals in Tehran, Iran, between 2016 and 2018, and followed them up for 5 48 months until April 30, 2022.

View Article and Find Full Text PDF

Hepatocellular carcinoma (HCC) is a major concern for public health. Fatty liver disease, related to alcohol misuse or metabolic syndrome, has become the leading cause of chronic liver disease and HCC. The strong association between type 2 diabetes mellitus and HCC can be partly attributed to the development of metabolic dysfunction associated steatotic liver disease (MASLD).

View Article and Find Full Text PDF

Aim: We investigated the possibility of caffeine supplementation for managing the inflammation, and hepatic function in cirrhotic patients.

Methods: In this randomized, double-blind, placebo-controlled trial, fifty patients with cirrhosis were randomly assigned to receive either caffeine supplement (400 mg), or placebo for eight weeks.

Results: The results indicated a significant decrease in AST, platelets (P = 0.

View Article and Find Full Text PDF

Background: Following a plant-based diet is associated with a wide range of health benefits. The current study aimed to investigate the association between plant-based diet indices, specifically the plant-based diet index (PDI), healthful PDI (hPDI), and unhealthful PDI (uPDI) and risk of mortality in cirrhotic patients.

Methods: This cohort study included a total of 121 patients with cirrhosis, who were followed for four years.

View Article and Find Full Text PDF

Liver Cirrhosis, defined as the final stage of chronic liver disease, may become more prevalent in the lower level of body defense against oxidation and inflammation. Therefore, we assessed the association of dietary total antioxidant capacity (DTAC) with the severity and mortality of cirrhosis in a cohort study. 120 newly diagnosed cirrhosis patients from Tehran, Iran, participated in this study.

View Article and Find Full Text PDF
Article Synopsis
  • Portal vein thrombosis (PVT) is a serious condition that can happen in people with liver disease called cirrhosis, which can cause bleeding and issues during liver transplants.
  • A study looked at 928 cirrhotic patients to see what factors might increase their risk of developing PVT, finding links to Hepatitis B, liver cancer, and certain symptoms like swollen belly and infections.
  • The results showed that older patients and those with higher MELD scores (which measure how badly the liver is damaged) are more likely to have PVT, suggesting doctors can help by keeping a close eye on these patients.
View Article and Find Full Text PDF
Article Synopsis
  • - The study investigates how dietary inflammatory indices affect the risk of mortality in patients with cirrhosis over 48 months by following 166 outpatients recently diagnosed with the condition.
  • - Dietary intake was assessed using a comprehensive 168-question food frequency questionnaire, leading to calculations of three inflammatory indices: DII, EDIP, and DIS.
  • - Results showed that higher dietary inflammatory indices significantly increased the mortality risk; for instance, the risk of death was 4.8 times higher for those in the highest DII category compared to the lowest.
View Article and Find Full Text PDF

Background And Purpose: The relationship between dietary patterns and cirrhosis is undeniable. The present study aimed to investigate the association between the Dietary Approaches to Stop Hypertension (DASH) diet and the risk of mortality in patients with cirrhosis prospectively.

Methods: In this cohort study, 121 cirrhotic patients were enrolled and followed up annually for four years.

View Article and Find Full Text PDF

This study investigated batch-fed vermicomposting of cow manure, with a specific focus on assessing the effects of tylosin on the weight of earthworms and the overall quality of the resulting manure. Five reactors, including three concentrations of tylosin (50, 100, and 150 mg/kg) and two control reactors, were employed. Residual tylosin concentrations were measured using high-performance liquid chromatography (HPLC).

View Article and Find Full Text PDF

Background: Non-alcoholic fatty liver disease (NAFLD) accounts as a crucial health concern with a huge burden on health and economic systems. The aim of this study is to evaluate the effect of soy isoflavones supplementation on metabolic status in patients with NAFLD.

Methods: In this randomized clinical trial, 50 patients with NAFLD were randomly allocated to either soy isoflavone or placebo groups for 12 weeks.

View Article and Find Full Text PDF

Background: To date, few studies have compared the effectiveness of exogenous surfactant therapy with Curosurf and Beraksurf in the treatment of respiratory distress syndrome (RDS) in preterm neonates.

Objective: Since surfactant has a significant impact on the treatment of neonates with RDS, this study was conducted to introduce a more effective method for treating preterm neonates with RDS.

Methods: The present clinical trial was conducted on 140 preterm neonates with RDS in the NICU department of two specialized university hospitals in Hamadan, western Iran.

View Article and Find Full Text PDF

Non-alcoholic fatty liver disease (NAFLD) is one of the leading causes of chronic liver diseases, affecting more than one-quarter of people worldwide. Hepatic steatosis can progress to more severe forms of NAFLD, including NASH and cirrhosis. It also may develop secondary diseases such as diabetes and cardiovascular disease.

View Article and Find Full Text PDF

A two-arm randomized open labeled controlled clinical trial was conducted on 50 patients with non-alcoholic fatty liver disease (NAFLD). Subjects were randomized to either receive two tablets of soy isoflavone (100 mg/day) or placebo. At week 12, the serum levels of alanine amino transferase (ALT), aspartate amino transferase (AST) and controlled attenuation parameter (CAP) score were significantly decreased only in the soy isoflavone group (P < 0.

View Article and Find Full Text PDF

As a global health concern, cirrhosis contributes significantly to morbidity and mortality. This prospective cohort study aimed to investigate the association between dietary acid load (DAL) and cirrhosis-related mortality. Present study was conducted on 121 patients with newly diagnosed cirrhosis who were followed up for 48 months.

View Article and Find Full Text PDF

Chronic liver diseases, especially cirrhosis, are associated with significant morbidity and mortality. Besides predisposing to chronic liver disease per se, diabetes, hypertension, and dyslipidemia worsen the prognosis of patients with cirrhosis induced by other causes. There is no standard of care in the management of these factors in patients with cirrhosis.

View Article and Find Full Text PDF

Background And Objectives: Non-alcoholic fatty liver disease (NAFLD) is a common liver disease with a rapidly growing incidence worldwide. For prognostication and therapeutic decisions, it is important to distinguish the pathological stages of NAFLD: steatosis, steatohepatitis, and liver fibrosis, which are definitively diagnosed on invasive biopsy. Non-invasive ultrasound (US) imaging, including US elastography technique, and clinical parameters can be used to diagnose and grade NAFLD and its complications.

View Article and Find Full Text PDF
Article Synopsis
  • * The study analyzed fecal microbiota in 15 NAFLD patients, 15 NASH patients, and 20 healthy individuals, finding that NAFLD and NASH patients had lower bacterial diversity and specific changes in microbial populations compared to healthy controls.
  • * The research identified increased levels of certain metabolic pathways in NAFLD patients and suggested that these findings may help develop new diagnostic methods and treatments tailored to different populations.
View Article and Find Full Text PDF

End-stage of liver fibrosis as a precancerous state could lead to cirrhosis and hepatocellular carcinoma which liver transplantation is the only effective treatment. Previous studies have indicated that farnesoid X receptor (FXR) agonists, such as obeticholic acid (OCA) protect against hepatic injuries. However, free OCA administration results in side effects in clinical trials that could be alleviated by applying bio carriers such as MSC-derived exosomes (Exo) with the potential to mimic the biological regenerative effect of their parent cells, as proposed in this study.

View Article and Find Full Text PDF
Article Synopsis
  • NAFLD is becoming a significant global health issue due to its increasing prevalence and risk of severe liver disease.
  • Research indicates that epigenetic factors, which affect gene expression without changing DNA, may link environmental influences to NAFLD's development and progression.
  • Recent studies focusing on processes like DNA methylation and microRNAs could lead to new diagnostic and treatment strategies, but more research is needed to clarify how exactly these epigenetic mechanisms work in NAFLD.
View Article and Find Full Text PDF

Objectives: Improving the oral health of the elderly is crucial to improving their general health and quality of life. To reach this goal, it is necessary to start with a comprehensive oral health assessment and a detailed treatment plan. The aim of this study was, therefore, to develop a comprehensive Oral Health Assessment Tool for the geriatric population.

View Article and Find Full Text PDF

Primary Sclerosing Cholangitis (PSC) is a chronic cholestatic liver disease which is associated with Inflammatory Bowel Disease (IBD) in 70% of cases. It seems PSC/IBD is a distinct phenotype that is different from PSC, and IBD alone. Hence, we review the epidemiology, pathogenesis, natural course and management of PSC/IBD before and after LT for PSC.

View Article and Find Full Text PDF
Article Synopsis
  • Liver fibrosis occurs when there's too much accumulation of extracellular matrix proteins, making early diagnosis challenging due to a lack of accurate non-invasive tests and the invasive nature of liver biopsies.
  • The study evaluates the diagnostic potential of specific circulating miRNAs (miR-146b, -194, -214) found in the blood of NAFLD patients and examines their role in the development of liver fibrosis.
  • Results indicated that miR-146b and miR-214 levels were significantly higher in NAFLD patients, while miR-194 was lower, suggesting these miRNAs could be used as non-invasive biomarkers for early liver fibrosis diagnosis and highlighting pathways like NF-κB activation and autophagy in their functioning.
View Article and Find Full Text PDF

Background: Liver cirrhosis is a worldwide burden and is associated with poor clinical outcomes, including increased mortality. The beneficial effects of dietary modifications in reducing morbidity and mortality are inevitable.

Aim: The current study aimed to evaluate the potential association of dietary protein intake with the cirrhosis-related mortality.

View Article and Find Full Text PDF

Liver fibrosis is characterized by the excessive deposition and accumulation of extracellular matrix components, mainly collagens, and occurs in response to a broad spectrum of triggers with different etiologies. Under stress conditions, autophagy serves as a highly conserved homeostatic system for cell survival and is importantly involved in various biological processes. Transforming growth factor-β1 (TGF-β1) has emerged as a central cytokine in hepatic stellate cell (HSC) activation and is the main mediator of liver fibrosis.

View Article and Find Full Text PDF
Article Synopsis
  • Liver fibrosis is a major health issue without an approved treatment, but previous studies show Imatinib can potentially reverse it despite its high side effects and required dosage due to conventional administration methods.
  • A new pH-sensitive polymer-based nanotherapeutic system has been developed using Vitamin A-modified Imatinib-loaded nanoparticles that release the drug effectively in the intestine while preventing premature release in the acidic stomach environment.
  • In experiments on mice with liver fibrosis, these targeted nanoparticles showed a strong accumulation in the liver, significantly improved liver enzyme levels, decreased collagen expression, and improved overall liver structure as assessed by various histological techniques.
View Article and Find Full Text PDF